Sun Pharmaceutical Industries has declared that USFDA has approved two ANDAs, general edition of Eloxatin, Oxaliplatin for injection and general edition of Imitrex, Sumatriptan Succinate pills.

Sun Pharmaceutical Industries has resolved its legal battle with MedImmune regarding the general edition of Ethyol.

Sun Pharmaceutical Industries presently trades at Rs.1150 on each share, which is high with 29.10 points on the Sensex.

Sun Pharmaceutical Industries has declared that USFDA has given its subordinate consent for an ANDA for generic Casodex, bicalutamide medicine.

44764 shares traded on BSE in the counter. The stock saw a standard everyday volume of 46298 shares in the last single quarter.

2.65lakh shares traded on BSE in the counter. The stock saw a standard everyday volume of 37,974 shares in the last single quarter.

Sun Pharmaceutical Industries’ subordinate has bagged USFDA consent for its Abbreviated New Drug Application to promote general Roxicodone, oxycodone hydrochloride tablets.

Sun Pharmaceutical Industries presently trades at Rs.1,049, which is up from its earlier closing of Rs.1,046.35 on the Sensex.

Sun Pharmaceutical Industries, drug major, along with its subsidiaries has acquired its first US Food and Drug Administration